SWS
BIIB icon

SYSTM Wealth Solutions’s Biogen BIIB Stock Holding History

SYSTM Wealth Solutions’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-69
Closed -$16K – 154
2024
Q2 		$16K Sell
69
-3
-4% -$652 ﹤0.01% 400
2024
Q1 		$15.5K Sell
72
-2
-3% -$468 ﹤0.01% 728
2023
Q4 		$19.1K Buy
+74
New +$18.2K ﹤0.01% 730
2023
Q1 		– Sell
-3,363
Closed -$931K – 471
2022
Q4 		$931K Buy
+3,363
New +$950K 0.12% 226

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SYSTM Wealth Solutions's BIIB Position: Q3 2024 in Review

SYSTM Wealth Solutions sold out of Biogen (BIIB) in Q3 2024, closing a stake of 69 shares — an estimated $16K sold.

SYSTM Wealth Solutions first reported a position in BIIB in Q4 2022 and held it in 4 quarters. The position peaked at $931K in Q4 2022. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • SYSTM Wealth Solutions reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • SYSTM Wealth Solutions sold 69 Biogen shares in Q3 2024, an estimated $16K.
  • SYSTM Wealth Solutions first reported a position in Biogen in Q4 2022 and held it in 4 quarters.
  • SYSTM Wealth Solutions's Biogen position peaked at $931K in Q4 2022.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.